NAN Stock: price and insider trades · Australia

NAN belongs to the Health Care sector. Filings by its managers are published through ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for NAN logged 7 filings by 6 insiders.

Every open-market trade in the period is a purchase: 3 purchases worth €51k, from 3 insiders, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The filings include the largest purchase, €33k, on 7 September 2026, which represents 0.0060% of the company's market value. Those buying include 3 senior executives.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 24 September 2026, which is 24 days ago. The median gap between a trade and its publication by ASX is 3 days. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (2,222 companies, median 3 filings), a count of 7 filings is above the norm. Since 2026, the database holds 3 purchases and no sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.